United States:
FDA Reopens Comment Period For Public Workshop On Liquid Chromatography/Mass-Spectrometry ("LC/MS")
To print this article, all you need is to be registered or login on Mondaq.com.
In the April 29, 2016, Federal Register, FDA announced it is
reopening the time period for interested persons to submit comments
on the public workshop initially announced in the March 9, 2016, Federal Register. As it did before,
FDA seeks comments on the workshop topics concerning the use of
LC/MS-based in vitro diagnostic devices in the clinical
laboratory. Comments were initially requested by April 20, 2016,
and the workshop was initially scheduled to take place May 2, 2016.
FDA is reopening the comment period in response to requests for
additional time. Comments are due June 2,
2016.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...